Overview
Melanoma incidence is increase in global population and number of transplantation also. However immunosuppressor increase recurrence risk of melanoma.
There are more and more cases of eligible patients to transplant with an antecedent of melanoma. There is no guideline yet.
Main objective is survival time without melanoma recurrence in this population to do guideline of time limit or not between melanoma and transplantation by stage.
Eligibility
Inclusion Criteria:
- patient with an antecedent of melanoma before transplantation
- Not opposite to participate
Exclusion Criteria:
- Under the age of 18
- patient under Guardianship
- patient not affiliated with a health system